BACKGROUND: Tricuspid valve (TV) @entity884 ( @entity884 ) is a known complication of @entity5275 ( @entity5275 ). This study assessed long-term outcomes of surgically and medically treated cases of TV @entity884 . METHODS: This was a retrospective cohort study of all cases of native TV @entity884 treated in London, Ontario between 2008 and 2011. Outcomes for medically and surgically managed cases were assessed at two years. Outcomes related to the timing of surgery were also assessed. RESULTS: Thirty-eight @entity1 were included; seven received valve surgery: five repairs, two replacements. All @entity1 had a history of @entity5275 . Baseline characteristics were equal in both groups. Death at two years was 43% in the surgical group and 26% in the nonsurgical group (p   =   0.522). In those who received surgery within 30 days versus after 30 days from admission, @entity204 was 33% and 50%, respectively (p   =   1.00). No @entity1 received emergent surgery (within seven days of admission). Twenty-nine percent of the surgical group survived disease free versus 52% of the nonsurgical group. Survival with morbidity was mainly related to ongoing @entity5275 . The highest risk for mortality in both groups was ongoing @entity5275 . CONCLUSIONS: In @entity5275 -related TV @entity884 the highest risk for mortality appears to be ongoing @entity5275 and persistent or recurrent @entity884 .

Surgical and Medical Management of Isolated Tricuspid XXXX in Intravenous Drug Users.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity5275 :: ('MESH:D015819', 'Disease') :: ['intravenous drug use', 'IVDU'] @entity884 :: ('MESH:D004696', 'Disease') :: ['IE', 'infective endocarditis', 'endocarditis']
@entity884 :: (MESH:D004696,Disease) :: ['Valve Infective Endocarditis']
